Creating Inclusive Clinical Trials

Complex enrollment systems often discourage patient participation in clinical trials, highlighting the need for accessible information and community engagement. LaToya Bolds-Johnson’s experience, shared during a recent webinar, underscores how challenging trial inclusion can be, even for those with a medical background. For many patients, understanding clinical trial processes can be daunting, especially without healthcare knowledge, and many healthcare providers are unaware of local trials which results in missed referral opportunities. By informing providers about nearby trials, patient referrals can increase, boosting participation and diversity. Education alone, however, is insufficient; community engagement is equally essential.

Community action boards (CABs), composed of local community members, can help build trust, adapt strategies to meet cultural needs, and enhance trial inclusivity. These boards facilitate conversations with pharmaceutical companies, helping to ensure that trial materials are relevant and accessible. Providing clear, jargon-free educational resources in multiple languages is another effective step toward increasing patient engagement and participation. Collaboration across the healthcare spectrum—pharmaceutical companies, regulatory bodies, patient advocates, and community leaders—is crucial for meaningful change. By fostering trust, addressing cultural needs, and making clinical trial information accessible, the industry can create pathways for broader patient representation.